Literature DB >> 11186425

The simultaneous presentation of sarcoidosis and common variable immune deficiency.

R Ameratunga1, D M Becroft, W Hunter.   

Abstract

Sarcoidosis and common variable immune deficiency can rarely present simultaneously in the same individual. We describe a child who presented with both disorders. The diagnosis of sarcoidosis was delayed because of the atypical appearances of the liver biopsy. She failed to respond to intravenous immunoglobulin but improved once cyclosporin and corticosteroids were added to her treatment regimen. It is important that the co-existence of both disorders is recognised so that treatment with a combination of intravenous immunoglobulin and immunosuppression can be in instituted to treat both the immune deficiency as well as the granulomatous disorder. As illustrated here, patients may fail to respond if either modality is used alone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11186425

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  14 in total

1.  Profound Reversible Hypogammaglobulinemia Caused by Celiac Disease in the Absence of Protein Losing Enteropathy.

Authors:  Rohan Ameratunga; Russell William Barker; Richard Henderson Steele; Maneka Deo; See-Tarn Woon; Mee Ling Yeong; Wikke Koopmans
Journal:  J Clin Immunol       Date:  2015-08-29       Impact factor: 8.317

2.  Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI).

Authors:  Wikke Koopmans; See-Tarn Woon; Anna E S Brooks; P Rod Dunbar; Peter Browett; Rohan Ameratunga
Journal:  J Clin Immunol       Date:  2012-09-15       Impact factor: 8.317

Review 3.  Review: Diagnosing Common Variable Immunodeficiency Disorder in the Era of Genome Sequencing.

Authors:  Rohan Ameratunga; Klaus Lehnert; See-Tarn Woon; David Gillis; Vanessa L Bryant; Charlotte A Slade; Richard Steele
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

Review 4.  New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin.

Authors:  R Ameratunga; S-T Woon; D Gillis; W Koopmans; R Steele
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

5.  Transient hypogammaglobulinaemia of infancy: many patients recover in adolescence and adulthood.

Authors:  R Ameratunga; Y Ahn; R Steele; S-T Woon
Journal:  Clin Exp Immunol       Date:  2019-07-22       Impact factor: 4.330

Review 6.  Development of granulomatous common variable immunodeficiency subsequent to infection with Toxoplasma gondii.

Authors:  S Mrusek; A Marx; J Kummerle-Deschner; N Tzaribachev; A Enders; U-N Riede; K Warnatz; G E Dannecker; S Ehl
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

Review 7.  Granulomatous disease in common variable immunodeficiency.

Authors:  Yoshikazu Morimoto; John M Routes
Journal:  Curr Allergy Asthma Rep       Date:  2005-09       Impact factor: 4.919

8.  Bronchiectasis is associated with delayed diagnosis and adverse outcomes in the New Zealand Common Variable Immunodeficiency Disorders cohort study.

Authors:  R Ameratunga; A Jordan; A Cavadino; S Ameratunga; T Hills; R Steele; M Hurst; B McGettigan; I Chua; M Brewerton; N Kennedy; W Koopmans; Y Ahn; R Barker; C Allan; P Storey; C Slade; A Baker; L Huang; S-T Woon
Journal:  Clin Exp Immunol       Date:  2021-04-12       Impact factor: 5.732

9.  Hypogammaglobulinemia factitia- Munchausen syndrome masquerading as common variable immune deficiency.

Authors:  Rohan Ameratunga; Paul Casey; Susan Parry; Chris Kenedi
Journal:  Allergy Asthma Clin Immunol       Date:  2013-09-17       Impact factor: 3.406

Review 10.  Comparison of diagnostic criteria for common variable immunodeficiency disorder.

Authors:  Rohan Ameratunga; Maia Brewerton; Charlotte Slade; Anthony Jordan; David Gillis; Richard Steele; Wikke Koopmans; See-Tarn Woon
Journal:  Front Immunol       Date:  2014-09-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.